Of note, ZMAT3 induction by the erytropoietin/erytropoietin receptor (Epo/EpoR) axis was reported in the papillary thyroid cancer subtype but not in others as anaplastic and follicular thyroid cancer [27]. The gene discussed is EPO; the disease is thyroid gland follicular carcinoma.